Anti-senile dementia medicine and preparation method thereof

A technology for senile dementia and drugs, applied in the field of medicine, can solve the problems of large toxic and side effects, inaccurate curative effect, weak specificity, etc., achieve good therapeutic effect, enhance the immune function of the host, and stimulate the formation of interferon.

Pending Publication Date: 2021-09-21
林德球
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The purpose of this application is to provide an anti-senile dementia drug and its preparation method, aiming to solve the problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-senile dementia medicine and preparation method thereof
  • Anti-senile dementia medicine and preparation method thereof
  • Anti-senile dementia medicine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0052] The second aspect of the embodiments of the present application provides a method for preparing an anti-senile dementia drug, comprising the steps of: mixing 30-60 parts of fucose, 10-40 parts of astragalus polysaccharide, 10-40 parts of lentinan and 20-40 parts of 50 parts of snake venom nerve growth factor are mixed and processed to prepare a pharmaceutically acceptable dosage form.

[0053] The preparation method of the anti-senile dementia drug provided in the second aspect of the present application is prepared by mixing 30-60 parts of fucose, 10-40 parts of astragalus polysaccharide, 10-40 parts of lentinan and 20-50 parts of snake venom nerve A pharmaceutically acceptable dosage form can be prepared by mixing and processing the growth factors, the preparation method is simple, the process is simple, and it is suitable for industrialized large-scale production and application.

[0054] In some embodiments, the step of preparing a pharmaceutically acceptable dosage...

Example Embodiment

[0056] Example 1

[0057] An anti-senile dementia drug, the preparation of which comprises the following steps: mixing 35 parts of fucose, 20 parts of astragalus polysaccharide, 20 parts of lentinan and 25 parts of snake venom nerve growth factor; tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicines, and particularly relates to an anti-senile dementia medicine and a preparation method thereof. When the total mass of the anti-senile dementia medicine is 100%, and the anti-senile dementia medicine comprises the following components: 30%-60% of fucose; 10%-40% of astragalus polysaccharide; 10%-40% of lentinan; and 20%-50% of snake venom nerve growth factors. The anti-senile dementia medicine provided by the invention has a better treatment effect on senile dementia through the synergistic effect of all the components, and can promote the release of acetylcholine in limbs and trunks, cause the balance of acetylcholine and dopamine in the brain, treat and relieve the symptoms of senile dementia and recover intelligence and memory to a certain extent.

Description

technical field [0001] The application belongs to the technical field of medicine, and in particular relates to an anti-senile dementia drug and a preparation method thereof. Background technique [0002] Alzheimer's disease is called Alzheimer's disease (Alzheimer's disease, AD), which was first described by German doctor Alois Alzheimer in 1906. It is a common cause of dementia, and its prevalence increases with age. 5%, about 20% of people over the age of 85. With the aging of the population, the incidence of AD is increasing year by year, seriously endangering the physical and mental health and quality of life of the elderly, causing great pain to the patient, and bringing a heavy burden to the family and society. The general concern of the government and the medical profession has become an urgent problem in modern medical research. As far as senile dementia is concerned, it is generally believed that it is a progressive decline due to organic or metabolic lesions of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/18A61P25/28A61K31/7004A61K31/715
CPCA61K38/185A61K31/7004A61K31/715A61P25/28A61K2300/00
Inventor 林德球曾伍江林洲林筱雅陈水春陈华胜
Owner 林德球
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap